Compare Fluence Energy Inc. Class A Common Stock (FLNC) vs NeoGenomics Inc. Common Stock (NEO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fluence Energy Inc. Class A Common Stock vs NeoGenomics Inc. Common Stock — how do they compare? Fluence Energy Inc. Class A Common Stock trades at $6.11 (market cap $969.93M), while NeoGenomics Inc. Common Stock trades at $16.83 (market cap $2.14B). The key difference: NeoGenomics Inc. Common Stock is far larger — about 2.2× Fluence Energy Inc. Class A Common Stock's market cap, and NeoGenomics Inc. Common Stock is trading nearer its 52-week high, Fluence Energy Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Fluence Energy Inc. Class A Common Stock for 0 Days and NeoGenomics Inc. Common Stock for 0 Days on average.
| FLNC | NEO | |
|---|---|---|
Market Cap | $969.93M | $2.14B |
Volume | 7,001,648 | 2,228,400 |
Sector | Utilities | Health |
52-Week High | $32.23 | $19.91 |
52-Week Low | $6.21 | $7.19 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $1.02B | $2.44B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Fluence Energy Inc. Class A Common Stock
Fluence Energy Inc. designs and delivers energy storage products, operational services, and asset optimization software for renewable-energy and storage applications worldwide.
Read more on FLNC →About NeoGenomics Inc. Common Stock
NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →
